Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: Implications for adult vaccination
Hanquet, G., Krizova, P., Valentiner-Branth, P., Ladhani, S.N., Nuorti, J.P., Lepoutre, A., Mereckiene, J., Knol, M., Winje, B.A., Ciruela, P., Ordobas, M., Guevara, M., Mcdonald, E., Morfeldt, E., Kozakova, J., Slotved, H.-C., Fry, N.K., Rinta-Kokko, H., Varon, E., Corcoran, M., Van Der Ende, A., Vestrheim, D.F., Munoz-Almagro, C., Latasa, P., Castilla, J., Smith, A., Henriques-Normark, B., Whittaker, R., Pastore Celentano, L., Savulescu, C.
Decline in early childhood respiratory tract infections in the norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccinationArchived
The study design and analysis controlled for influence of potentially confounding trends, such as improvement of day-care carriage and decreasing prevalence of smoking during the study period.
Four years of universal pneumococcal conjugate infant vaccination in Germany: Impact on incidence of invasive pneumococcal disease and serotype distribution in childrenArchived
The study compares the incidence and serotype distribution of invasive pneumococcal disease (IPD) for pneumococcal meningitis and non-meningitis IPD in children from 2007 to 2010 with reference to the pre-vaccination period from 1997 to 2001 in Germany.